News | May 23, 2021
Bharat Parenterals receives license for Favipiravir Oral Suspension
The product patent has been already filed under fast track approval
The product patent has been already filed under fast track approval
The decision now moves to the European Commission, with a final ruling expected by the third quarter of 2026
The trial will assess Precem-TcT, both as monotherapy and in combination with bevacizumab, in patients whose disease has progressed after or become resistant to standard treatments
Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond
Solutions designed to help clinicians reduce administrative burden, improve diagnostic accuracy, and spend more time with patients
Pfizer says the broader dataset across all 25 serotypes strengthens confidence that the program can meet non-inferiority thresholds in its upcoming Phase 3 pediatric trials
Dr. Upadhyay brings over 25 years of global leadership experience across life sciences, regulated manufacturing, diagnostics, and research-led environments
By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic
Union Health Minister highlights India’s progress in universal health coverage, digital health, AI strategy and global vaccine cooperation during plenary session in Geneva
Subscribe To Our Newsletter & Stay Updated
